CVS Limits Purchases of Rapid Covid-19 Tests, Citing Demand

 CVS Health Corp. is limiting customers’ purchases of rapid, over-the-counter Covid-19 tests, with a maximum of six packages available online and four in its pharmacies, as the spread of the delta variant spurs demand.

Put in place this week, the limits apply to Abbott Laboratories’s BinaxNOW along with a test from the startup Ellume, according to an email from a CVS spokesperson. Both tests are available without a prescription.

Surging interest in rapid virus tests have made the products a scarce commodity at some online retailers and in certain stores. 

https://news.bloomberglaw.com/health-law-and-business/cvs-limits-purchases-of-rapid-covid-19-tests-citing-demand